Fig. 1From: Reduction in the incidence of myocardial infarction with sodium–glucose linked cotransporter-2 inhibitors: evident and plausiblereproduced with permission from [2]Myocardial infarction, stroke and amputation events in EMPA-REG Outcome, CANVAS and DECLARE studies, Back to article page